StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note issued to investors on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
SRNE stock opened at $0.02 on Monday. The business’s 50-day moving average price is $0.02 and its two-hundred day moving average price is $0.05. Sorrento Therapeutics has a 1-year low of $0.00 and a 1-year high of $0.42.
About Sorrento Therapeutics
Recommended Stories
- Five stocks we like better than Sorrento Therapeutics
- What is the S&P/TSX Index?
- AMD is Down 35%. Now is the Time to Buy the Dip
- Conference Calls and Individual Investors
- Amazon Stands Tall: New Highs Are in Sight
- What is a Secondary Public Offering? What Investors Need to Know
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.